GLP-1 Consumer Research

Original consumer survey data on the real-world experience of GLP-1 weight loss medication users — cost, stigma, cravings, quitting, and public opinion.

Self-funded. No affiliate links. No ads.

Topline Findings

~12%

of U.S. adults report currently using or having recently used a GLP-1 medication

KFF Health Tracking Poll, Nov 2025

82%

of U.S. adults say prescription drug costs are unreasonable

KFF/Peterson, 2024

45M+

GLP-1 prescriptions dispensed in the U.S. in 2023

IQVIA Institute, 2024

27%

of GLP-1 users report experiencing judgment for using weight loss medication

Ro Health Survey, 2024

Methods at a Glance

Status

In development

Target sample

n=500+ U.S. adults

Platform

Prolific (opt-in)

Limitations

Self-reported; not causal

Read full methodology →

Research

GLP-1 Statistics Hub

14 key findings

Comprehensive statistics on GLP-1 usage, cost, clinical outcomes, and consumer experience. Sourced from KFF, CDC, IQVIA, CMS, and peer-reviewed trials.

GLP-1 Pricing Index

Live data

Live telehealth provider pricing tracker with historical data, trend analysis, and change logs.

Secrecy & Stigma

Survey data

How many users hide their GLP-1 use and the social dynamics of weight loss medication.

Cost & Financial Impact

Survey data

Financial sacrifices, insurance barriers, and out-of-pocket costs for GLP-1 medications.

Cravings & Alcohol

Survey data

Self-reported changes in alcohol consumption, food cravings, and compulsive behaviors.

Stopping & Quitting

Survey data

Self-reported experiences, weight regain data, and reasons for discontinuing GLP-1 medications.

Public Opinion & Dating

Survey data

How surveyed U.S. adults view GLP-1 users and the impact on dating and relationships.

Resources

Methodology

Survey design, sample details, and funding disclosures

Editorial Policy

How we source, verify, and update research data

Press Kit

Downloadable charts, key findings, and media assets

Changelog

Data updates and revision history

Contact

Press inquiries and data requests

Methodology & Disclosures

Collected via Prolific, an online research participant platform (U.S.-based respondents). This is a nonprobability, opt-in sample and is not nationally representative. Full methodology, sample details, and funding disclosures are published transparently.

Read full methodology →

Media & Press

For press inquiries, original data requests, or downloadable charts:

[email protected]

Response time: typically <24 hours